EUVIMEDOdkrijte EUVIMED
Crossref

Small cell neuroendocrine carcinoma of the cervix: diagnostic challenges and emerging molecular insights †

Alphonse Charbel, Gaëlle Akiki, Sarah-Slim Diwan, Shuk On Annie Leung iD, Felix Kf Kommoss iD, Basile Tessier-Cloutier iD

The Journal of Pathology · 2026

DOI: 10.1002/path.6486 ↗

At a glance

Journal article in The Journal of Pathology, 2026. Written by Alphonse Charbel and 5 co-authors. Institution: Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany. Major MEDLINE topics: Carcinoma, Neuroendocrine, Uterine Cervical Neoplasms, Carcinoma, Small Cell, Biomarkers, Tumor. Cited 2 times so far (Crossref); 10 references. Funded by: Fonds de Recherche du Québec - Santé, Terry Fox Research Institute.

PovzetekSubjectsBibliografski podatkiCiteRelated studies

Abstract (original language)

Small cell neuroendocrine carcinoma of the cervix (SCNECC) is a rare and highly aggressive malignancy with poor prognosis that predominantly affects premenopausal women. Histopathological evaluation is central to diagnosis and clinical management; however, distinguishing SCNECC from other ‘small blue round cell’ malignancies often requires a multimodal approach that integrates morphology, immunohistochemistry, and advanced molecular testing. In the absence of specific and sensitive biomarkers, SCNECC largely remains a diagnosis of exclusion, underscoring the need for comprehensive diagnostic algorithms. A study by Pan, Yan, Yuan et al employed whole transcriptome profiling and identified three molecular subgroups within SCNECC. Importantly, one subgroup displayed an inflamed phenotype, characterized by high expression of MHC‐II complex and IFN‐α/β–related genes, suggesting potential susceptibility to immunotherapy, a finding that mirrors observations in small cell lung cancer. These findings highlight the biological heterogeneity of SCNECC and reinforce the importance of integrating molecular data to refine diagnostic accuracy and guide therapeutic decision‐making. This commentary emphasizes the pressing need for comprehensive diagnostics and further research to advance treatment strategies for this rare and challenging malignancy. © 2025 The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

Carcinoma, NeuroendocrineUterine Cervical NeoplasmsCarcinoma, Small CellBiomarkers, TumorHumansFemaleGene Expression Profiling

Author keywords

cervixgene expressionsmall cell neuroendocrine carcinomasmall round blue cell tumorundifferentiated carcinoma

Substances

Biomarkers, Tumor

Authors and institutions

  • Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Department of Pathology, McGill University, Montreal, Canada.
  • Department of Obstetrics and Gynecology, McGill University Health Centre, Montreal, Canada.
  • Department of Pathology, McGill University Health Centre, Montreal, Canada.

ORCID profiles: Shuk On Annie Leung, Felix Kf Kommoss, Basile Tessier-Cloutier

Funding

  • Fonds de Recherche du Québec - Santé
  • Terry Fox Research Institute

Cite

APA

Charbel, A., Akiki, G., Diwan, S. S., Leung, S. O. A., Kommoss, F. K., & Tessier-Cloutier, B. (2026). Small cell neuroendocrine carcinoma of the cervix: diagnostic challenges and emerging molecular insights †. The Journal of Pathology. https://doi.org/10.1002/path.6486

Vancouver

Charbel A, Akiki G, Diwan SS, Leung SOA, Kommoss FK, Tessier-Cloutier B. Small cell neuroendocrine carcinoma of the cervix: diagnostic challenges and emerging molecular insights †. The Journal of Pathology. 2026. doi:10.1002/path.6486

BibTeX
@article{Charbel2026,
  author = {Charbel, Alphonse and Akiki, Gaëlle and Diwan, Sarah-Slim and Leung, Shuk On Annie and Kommoss, Felix Kf and Tessier-Cloutier, Basile},
  title = {Small cell neuroendocrine carcinoma of the cervix: diagnostic challenges and emerging molecular insights †},
  journal = {The Journal of Pathology},
  year = {2026},
  doi = {10.1002/path.6486}
}
Start for free →